Globus Medical (GMED) fundamentals: P/E, valuation, undervalued?
Globus Medical · Health Care · ref. ETF XLV · price $76.32
In short — Globus Medical trades at 19.6× earnings (P/E), 14.1× forward, with a net margin of 17.0 % and revenue growth of +6 %. Read: Average P/E (P/E 20 (near the ~20-25 average)).
Is Globus Medical stock cheap or undervalued? A good time to buy? Here are its fundamentals — P/E, PEG, margin and income statement — to judge its valuation.
📈 1-year price
$76.32+31.4% over range
Oct 14, 25low $58.09 · high $96.82Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
75% recommend buying · 8 analysts
Valuation : Average P/E — P/E 20 (near the ~20-25 average)
Valuation
19.6
P/E (price/earnings)
14.1
Forward P/E
—
PEG
2.1
Price/book (P/B)
$10.2B
Market cap
3.90
EPS
Profitability & growth
17.0 %
Net margin
+6 %
Revenue growth
-26 %
Earnings growth
$112M
Total debt
Globus Medical income statement
| Fiscal year | Revenue | Net income | Margin |
|---|---|---|---|
| 2022 | $1.0B | $190M | 18.6 % |
| 2023 | $1.6B | $123M | 7.8 % |
| 2024 | $2.5B | $103M | 4.1 % |
| 2025 | $2.9B | $538M | 18.3 % |
⚠️ Indicative financial data (Yahoo Finance), not investment advice. Amounts in $.
Frequently asked questions
What is Globus Medical's P/E and is the stock undervalued? What's a good P/E?
Globus Medical's P/E is 19.6 (forward 14.1). Below ~15 = fairly cheap, above ~30 = expensive. Our valuation verdict: "Average P/E".
Is Globus Medical profitable?
Globus Medical has a net margin of 17.0 % (EPS 3.90). The company is profitable.
Is GMED stock expensive?
Our read: "Average P/E" — P/E 20 (near the ~20-25 average). Cross-check with growth and sector.
💬 A question about Globus Medical? The JPI assistant answers using our backtest data.
Keep exploring Globus Medical